PHARMACYTE BIOTECH, INC. Payments to Acquire Investments
PHARMACYTE BIOTECH, INC. (PMCB) reported Payments to Acquire Investments of $3.00 million for the 6-month period ending 2025-10-31, per its 10-Q filed 2025-12-18.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2025-12-18
- PHARMACYTE BIOTECH, INC. payments to acquire investments for the quarter ending 2025-10-31 was $3.00M.
- PHARMACYTE BIOTECH, INC. payments to acquire investments for the quarter ending 2025-07-31 was $0.00, a 100.00% decline year-over-year.
- PHARMACYTE BIOTECH, INC. payments to acquire investments for the quarter ending 2025-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. payments to acquire investments for the quarter ending 2025-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. payments to acquire investments for fiscal 2025 was $7.00M.
- PHARMACYTE BIOTECH, INC. payments to acquire investments for fiscal 2024 was $0.00.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2025-10-31 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-18 | $3.00M 10-Q · filed 2025-12-18 | $3.00M derived: sum of 3 quarters · filed 2025-12-18 | $3.00M derived: sum of 4 quarters · filed 2025-12-18 |
| 2025-07-31 | $0.00 10-Q · filed 2025-09-15 | $0.00 derived: sum of 2 quarters · filed 2025-09-15 | $0.00 derived: sum of 3 quarters · filed 2025-09-15 | $0.00 derived: sum of 4 quarters · filed 2025-12-18 |
| 2025-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | $0.00 derived: sum of 2 quarters · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2025-12-18 | $7.00M 10-K · filed 2025-08-11 |
| 2025-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-12-18 | $7.00M 10-Q · filed 2025-03-17 | $7.00M derived: sum of 4 quarters · filed 2025-12-18 |
| 2024-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-18 | $7.00M 10-Q · filed 2025-12-18 | $7.00M derived: sum of 3 quarters · filed 2025-12-18 | $7.00M derived: sum of 4 quarters · filed 2025-12-18 |
| 2024-07-31 | $7.00M 10-Q · filed 2025-09-15 | $7.00M derived: sum of 2 quarters · filed 2025-09-15 | $7.00M derived: sum of 3 quarters · filed 2025-09-15 | $7.00M derived: sum of 4 quarters · filed 2025-09-15 |
| 2024-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | $0.00 derived: sum of 2 quarters · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2025-08-11 | $0.00 10-K · filed 2025-08-11 |
| 2024-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | $0.00 10-Q · filed 2025-03-17 | |
| 2023-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-13 | $0.00 10-Q · filed 2024-12-13 | ||
| 2023-07-31 | $0.00 10-Q · filed 2024-09-17 | |||
| 2013-10-31 | $1.57M 10-Q · filed 2013-12-16 | |||
| 2012-10-31 | $1.52M 10-Q · filed 2013-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |